Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-trace').style.display = (document.getElementById('cakeErr68035d2a4ae8f-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68035d2a4ae8f-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-code').style.display = (document.getElementById('cakeErr68035d2a4ae8f-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-context').style.display = (document.getElementById('cakeErr68035d2a4ae8f-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68035d2a4ae8f-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68035d2a4ae8f-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 18228,
		&#039;title&#039; =&gt; &#039;Focus on spurious, substandard drugs is more important&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;
&lt;br /&gt;
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;
&lt;br /&gt;
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;
&lt;br /&gt;
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;focus-on-spurious-substandard-drugs-is-more-important-18357&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 18357,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 18228,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;&lt;br /&gt;More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;&lt;br /&gt;Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;&lt;br /&gt;The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 18228,
	&#039;title&#039; =&gt; &#039;Focus on spurious, substandard drugs is more important&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;
&lt;br /&gt;
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;
&lt;br /&gt;
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;
&lt;br /&gt;
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;focus-on-spurious-substandard-drugs-is-more-important-18357&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 18357,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 18228
$metaTitle = &#039;LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;&lt;br /&gt;More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;&lt;br /&gt;Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;&lt;br /&gt;The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important | Im4change.org</title>
    <meta name="description" content="
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Focus on spurious, substandard drugs is more important</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times<br /><br />The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br /><br />More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br /><br />Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br /><br />The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-trace').style.display = (document.getElementById('cakeErr68035d2a4ae8f-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68035d2a4ae8f-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-code').style.display = (document.getElementById('cakeErr68035d2a4ae8f-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-context').style.display = (document.getElementById('cakeErr68035d2a4ae8f-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68035d2a4ae8f-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68035d2a4ae8f-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 18228,
		&#039;title&#039; =&gt; &#039;Focus on spurious, substandard drugs is more important&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;
&lt;br /&gt;
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;
&lt;br /&gt;
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;
&lt;br /&gt;
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;focus-on-spurious-substandard-drugs-is-more-important-18357&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 18357,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 18228,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;&lt;br /&gt;More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;&lt;br /&gt;Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;&lt;br /&gt;The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 18228,
	&#039;title&#039; =&gt; &#039;Focus on spurious, substandard drugs is more important&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;
&lt;br /&gt;
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;
&lt;br /&gt;
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;
&lt;br /&gt;
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;focus-on-spurious-substandard-drugs-is-more-important-18357&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 18357,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 18228
$metaTitle = &#039;LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;&lt;br /&gt;More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;&lt;br /&gt;Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;&lt;br /&gt;The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important | Im4change.org</title>
    <meta name="description" content="
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Focus on spurious, substandard drugs is more important</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times<br /><br />The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br /><br />More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br /><br />Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br /><br />The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-trace').style.display = (document.getElementById('cakeErr68035d2a4ae8f-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68035d2a4ae8f-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-code').style.display = (document.getElementById('cakeErr68035d2a4ae8f-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68035d2a4ae8f-context').style.display = (document.getElementById('cakeErr68035d2a4ae8f-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68035d2a4ae8f-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68035d2a4ae8f-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 18228,
		&#039;title&#039; =&gt; &#039;Focus on spurious, substandard drugs is more important&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;
&lt;br /&gt;
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;
&lt;br /&gt;
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;
&lt;br /&gt;
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;focus-on-spurious-substandard-drugs-is-more-important-18357&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 18357,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 18228,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;&lt;br /&gt;More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;&lt;br /&gt;Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;&lt;br /&gt;The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 18228,
	&#039;title&#039; =&gt; &#039;Focus on spurious, substandard drugs is more important&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;
&lt;br /&gt;
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;
&lt;br /&gt;
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;
&lt;br /&gt;
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;focus-on-spurious-substandard-drugs-is-more-important-18357&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 18357,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 18228
$metaTitle = &#039;LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or &#039;generic generics&#039;, although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.&lt;br /&gt;&lt;br /&gt;More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.&lt;br /&gt;&lt;br /&gt;Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.&lt;br /&gt;&lt;br /&gt;The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/focus-on-spurious-substandard-drugs-is-more-important-18357.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important | Im4change.org</title>
    <meta name="description" content="
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Focus on spurious, substandard drugs is more important</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times<br /><br />The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br /><br />More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br /><br />Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br /><br />The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 18228,
		'title' => 'Focus on spurious, substandard drugs is more important',
		'subheading' => '',
		'description' => '<div align="justify">
-The Economic Times<br />
<br />
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br />
<br />
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br />
<br />
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br />
<br />
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br />
<br />
</div>',
		'credit_writer' => 'The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'focus-on-spurious-substandard-drugs-is-more-important-18357',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 18357,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 18228,
	'metaTitle' => 'LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important',
	'metaKeywords' => 'medicines,Health',
	'metaDesc' => '
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...',
	'disp' => '<div align="justify">-The Economic Times<br /><br />The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br /><br />More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br /><br />Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br /><br />The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br /><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 18228,
	'title' => 'Focus on spurious, substandard drugs is more important',
	'subheading' => '',
	'description' => '<div align="justify">
-The Economic Times<br />
<br />
The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br />
<br />
More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br />
<br />
Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br />
<br />
The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br />
<br />
</div>',
	'credit_writer' => 'The Economic Times, 29 November, 2012, http://economictimes.indiatimes.com/opinion/editorial/focus-on-spurious-substandard-drugs-is-more-important/articleshow/17408868.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'focus-on-spurious-substandard-drugs-is-more-important-18357',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 18357,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 18228
$metaTitle = 'LATEST NEWS UPDATES | Focus on spurious, substandard drugs is more important'
$metaKeywords = 'medicines,Health'
$metaDesc = '
-The Economic Times

The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought...'
$disp = '<div align="justify">-The Economic Times<br /><br />The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers.<br /><br />More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production.<br /><br />Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements.<br /><br />The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.<br /><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Focus on spurious, substandard drugs is more important

-The Economic Times The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well, the market-based method of price cap seems to be a step in the right direction. It would appear to favour low-cost, unbranded generic drugs, or 'generic generics', although what doctors actually prescribe may well be a function of focused marketing on the part of branded drug producers. More importantly, the pricing policy aims to vastly enlarge the scope for price control to over 30% of the market, 348 drugs, up from 74 bulk drugs and formulations. Apart from being a complete reversal of the policy of recent years, it would have myriad unintended consequences given the real problem of spurious and substandard drugs in a Rs 65,000-crore industry with long tails of drug firms in most segments. Note that back in 1970, 100% of drugs were under price control, but the ratio was progressively reduced to allow rigorous price competition in the large domestic pharma market. Note also that the Pronab Sen task force on drug pricing in 2005 put the extent of price control at just about 10% of total drugs production. Successive expert panels have recommended a reasonably small national list of essential medicines for effective policy implementation. We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory overreach, given the oversight and monitoring requirements. The drug regulatory mechanism needs to be significantly strengthened both at the Centre and the states. As for methodology of price control, it would make sense to provide flexibility and opt, say, for the median (most prevalent) price instead of mechanically insisting on the arithmetic mean price in a segment. Otherwise, producers may simply stop production of certain drugs.